Form 4 for IMAX IMAX CORP

Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-09 · accession 0001214659-24-020103 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-12-09	2024-12-09	IMAX	Fernandes Natasha	CFO, EVP	C - Cnv Deriv	$20.85	+2,957	17.8K	+20%	+$61.7K
D	2024-12-09	2024-12-09	IMAX	Fernandes Natasha	CFO, EVP	S - Sale	$25.52	-2,957	14.9K	-17%	-$75.5K
D	2024-12-09	2024-12-09	IMAX	Fernandes Natasha	CFO, EVP	C - Cnv Deriv	$20.85	-2,957	0	-100%	-$61.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	common shares	2024-12-09	C	A	2,957	$20.85	17,840	D	—	—	(F1) Represents the conversion upon exercise of stock options into common shares.
2	Common	common shares	2024-12-09	S	D	2,957	$25.52	14,883	D	—	—
3	Derivative	stock options (to buy)	2024-12-09	C	D	2,957	$20.85	0	D	$20.85 · — to 2025-03-07	2,957 common shares	(F2) These options were issued in 2018 and are set to expire on March 7, 2025. The transaction was driven solely by the upcoming expiration of the options and the issuer's fourth quarter trading blackout period that commences on December 18, 2024. The trading blackout will end 24 hours after the issuer's earnings release in February 2025. (F4) This represents the number of stock options for this transaction only. Ms. Fernandes' aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 2,652, 44,984 and 14,883, respectively. (F3) The stock options became exercisable in four installments: 591 on March 7, 2019, 739 on each of March 7, 2020 and March 7, 2021 and 888 on March 7, 2022.